NCT06937983View on ClinicalTrials.gov

Optimised Decrement Evoked Potential (DeEP) Mapping to Guide Ventricular Tachycardia (VT) Ablation in Patients With Structural Heart Disease VT

NARecruitingINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

April 11, 2025

Primary Completion Date

December 3, 2027

Study Completion Date

December 3, 2027

Conditions
Structural Heart Disease
Interventions
PROCEDURE

Optimised DeEP-guided ablation

Optimised decrement evoked potential (DeEP) mapping in VT ablation.

Trial Locations (1)

CV2 2DX

RECRUITING

University Hospitals Coventry & Warwickshire NHS Trust, Coventry

All Listed Sponsors
lead

University Hospitals Coventry and Warwickshire NHS Trust

OTHER